Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Red Queen Bio
AddedJun 26, 2026
UpdatedJul 6, 2026
Red Queen Bio

Red Queen Bio

Red Queen Bio maps AI-enabled biothreats and pre-builds medical countermeasures at scale.

HQ
Boston, MA, US
Founded
2025
Overview
Compare
Employees

Red Queen Bio is an AI biosecurity Public Benefit Corporation focused on defensive co-scaling in biology. The company was founded by Hannu Rajaniemi and Nikolai, former co-founders of HelixNano, and spun out with a $15 million seed round led by OpenAI.

Red Queen Bio's core thesis is defensive co-scaling: coupling defensive compute and funding to the same technological and financial forces that drive the capability race. The company works with frontier labs to map AI-enabled biothreats and pre-build medical countermeasures against them, engineering the process to be directly scalable with compute.

Red Queen Bio - Products & Services

  • AI Biosecurity Countermeasures logo

    AI Biosecurity Countermeasures

    AI Biosecurity Countermeasures maps AI-enabled biothreats and pre-builds medical countermeasures at scale.

    Competing Products

    Valthos logo

Red Queen Bio - Similar Companies

Valthos logo

Valthos

Red Queen Therapeutics logo

Red Queen Therapeutics

redqueentx.com

AminoAnalytica logo

AminoAnalytica

aminoanalytica.com

CellType logo

CellType

celltype.com

AbInitio Bio logo

AbInitio Bio

abinitio-bio.com

Radical Numerics logo

Radical Numerics

radicalnumerics.ai

TwentyTwo logo

TwentyTwo

twentytwo.bio

Q32 Bio logo

Q32 Bio

q32bio.com

Biotechonomy logo

Biotechonomy

Nano RED logo

Nano RED

Mana.bio logo

Mana.bio

mana.bio

Generate Biomedicines logo

Generate Biomedicines

Biotia logo

Biotia

biotia.io

Maven Bio logo

Maven Bio

mavenbio.com

Curie.Bio logo

Curie.Bio

curie.bio

Red Queen Bio - Quick Facts

Who are Red Queen Bio's competitors?

Companies similar to Red Queen Bio include Valthos, Red Queen Therapeutics, AminoAnalytica and CellType.

When was Red Queen Bio founded?

Red Queen Bio was founded in 2025.

Where is Red Queen Bio's headquarters located?

Red Queen Bio's headquarters is located in Boston, MA, US.

Red Queen Bio - Classification

Industry
  • Biotechnology